Back to Authors

Roblin, Steven

A5066558790 | I145311141

Mayo Clinic

Alnylam Pharmaceuticals (United States)

Citations 1

Impact of patisiran on polyneuropathy of hereditary transthyretin amyloidosis in patients with a V122I or T60A variant: a phase IV multicenter study

Annals of Medicine | September 20, 2025 | Volume: 57 | Issue: 1 | Pages: No page available

10.1080/07853890.2025.2537347 | PMID 40974604